These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1721295)

  • 1. Is FKBP involved in the immunosuppressive and/or toxic mechanism of action of FK 506?
    Sigal NH; Dumont FJ; Siekierka JJ; Wiederrecht G; Parent SA; Brizuela L
    Transplant Proc; 1991 Dec; 23(6):2846-9. PubMed ID: 1721295
    [No Abstract]   [Full Text] [Related]  

  • 2. Antifungal effects of cyclosporine and FK 506 are mediated via immunophilin-dependent calcineurin inhibition.
    Heitman J; Cardenas ME; Breuder T; Hemenway C; Muir RS; Lim E; Goetz L; Zhu D; Lorenz M; Dolinski K
    Transplant Proc; 1994 Oct; 26(5):2833-4. PubMed ID: 7524220
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of T-cell signaling pathways by immunophilin drug complexes: are side effects inherent to immunosuppressive properties?
    Schreier MH; Baumann G; Zenke G
    Transplant Proc; 1993 Feb; 25(1 Pt 1):502-7. PubMed ID: 7679818
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclosporin A, FK506, and rapamycin: binding to immunophilins and biological action.
    Bierer BE
    Chem Immunol; 1994; 59():128-55. PubMed ID: 7524531
    [No Abstract]   [Full Text] [Related]  

  • 5. Potential roles of other FK 506-binding proteins in mediating the effects of FK 506.
    Siekierka JJ; Wiederrecht G; Cryan J; Hung SH; Comisky M; Sigal NH
    Transplant Proc; 1991 Dec; 23(6):2720-1. PubMed ID: 1721256
    [No Abstract]   [Full Text] [Related]  

  • 6. Yeast cyclophilin-related gene encodes a nonessential second peptidyl-prolyl cis-trans isomerase associated with the secretory pathway.
    Tanida I; Yanagida M; Maki N; Yagi S; Namiyama F; Kobayashi T; Hayano T; Takahashi N; Suzuki M
    Transplant Proc; 1991 Dec; 23(6):2856-61. PubMed ID: 1721297
    [No Abstract]   [Full Text] [Related]  

  • 7. Gene expression of FK 506-binding protein.
    Kar S; Carr B
    Transplant Proc; 1991 Dec; 23(6):2880-2. PubMed ID: 1721303
    [No Abstract]   [Full Text] [Related]  

  • 8. Proline isomerases at the crossroads of protein folding, signal transduction, and immunosuppression.
    Heitman J; Movva NR; Hall MN
    New Biol; 1992 May; 4(5):448-60. PubMed ID: 1515410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-function relationships in the FK506-binding protein (FKBP) family of peptidylprolyl cis-trans isomerases.
    Kay JE
    Biochem J; 1996 Mar; 314 ( Pt 2)(Pt 2):361-85. PubMed ID: 8670043
    [No Abstract]   [Full Text] [Related]  

  • 10. FK-506 and cyclosporin A: immunosuppressive mechanism of action and beyond.
    Siekierka JJ; Sigal NH
    Curr Opin Immunol; 1992 Oct; 4(5):548-52. PubMed ID: 1384551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptidylproline cis/trans isomerases.
    Galat A; Metcalfe SM
    Prog Biophys Mol Biol; 1995; 63(1):67-118. PubMed ID: 7538221
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of calcineurin's role in the immunosuppressive activity of FK 506, related macrolactams, and cyclosporine.
    Lane BC; Miller LN; Kawai M; Or YS; Wiedeman P; Holzman TF; Luly JR
    Transplant Proc; 1993 Feb; 25(1 Pt 1):644-6. PubMed ID: 7679829
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunity, microbial pathogenesis, and immunophilins: finding the keys, now where are the locks?
    High KP; Handschumacher RE
    Infect Agents Dis; 1992 Jun; 1(3):121-35. PubMed ID: 1285413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin.
    Dumont FJ; Staruch MJ; Koprak SL; Siekierka JJ; Lin CS; Harrison R; Sewell T; Kindt VM; Beattie TR; Wyvratt M
    J Exp Med; 1992 Sep; 176(3):751-60. PubMed ID: 1380976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FK-506-binding proteins from streptomycetes producing immunosuppressive macrolactones of the FK-506 type.
    Pahl A; Keller U
    J Bacteriol; 1992 Sep; 174(18):5888-94. PubMed ID: 1381710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FKB1 encodes a nonessential FK 506-binding protein in Saccharomyces cerevisiae and contains regions suggesting homology to the cyclophilins.
    Wiederrecht G; Brizuela L; Elliston K; Sigal NH; Siekierka JJ
    Proc Natl Acad Sci U S A; 1991 Feb; 88(3):1029-33. PubMed ID: 1704127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction.
    Sigal NH; Dumont FJ
    Annu Rev Immunol; 1992; 10():519-60. PubMed ID: 1375473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FK506 and protein kinase C.
    Tropschug M; Hofmann R
    Nature; 1991 May; 351(6323):195. PubMed ID: 1710319
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular basis of immunosuppressive drug action: regulation of steroid receptor-mediated transcription by FK 506.
    Butt TR; Graumann K; Aziz S
    Transplant Proc; 1996 Apr; 28(2):979-80. PubMed ID: 8623486
    [No Abstract]   [Full Text] [Related]  

  • 20. The mechanism of action of FK-506 and cyclosporin A.
    Wiederrecht G; Lam E; Hung S; Martin M; Sigal N
    Ann N Y Acad Sci; 1993 Nov; 696():9-19. PubMed ID: 7509138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.